Factory Supply Cinnarizine CAS 298-57-7 Pharmaceutical Grade Cinnarizine Powder

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: HB-Cinnarizine
• Suitable for: Adult
• State: Powder
• Purity: >99%
• Shelf Life: 2 Years
• Storage: Cool Dry Place
• Packing: Rum, Aluminum Foil Bag
• MOQ: 1kg
• CAS: 298-57-7
• Sample: Available
• Transport Package: Rum, Aluminum Foil Bag
• Specification: 99%
• Trademark: Haibo
• Origin: Shaanxi, China
• HS Code: 2933599099
• Production Capacity: 50000/Pieces/Years

Product Description

Cinnarizine is a medication derivative of characterized as an antihistamine and a calcium channel blocker, it is also known to promote cerebral blood flow, and so is used to treat cerebral apoplexy, post-trauma cerebral symptoms, and cerebral arteriosclerosis. However, it is more commonly prescribed for nausea and vomiting due to motion sickness or other sources such as chemotherapy, vertigo, or Ménière's disease. Cinnarizine was first synthesized by Janssen Pharmaceutica in 1955. The nonproprietary name is derived from the cinnamyl substituent on one of the nitrogen atoms, combined with the generic ending "-rizine" for "antihistaminics/cerebral (or peripheral) vasodilators". It is not available in the United States or Canada. It is manufactured and marketed in Bangladesh under the trade name Suzaraon by Rephco Pharmaceuticals Limited. It has also been cited as one of the most used drugs for seasickness within the British Royal Navy.

 

 

Item	Test Standard		Testing Result
Assay	99%		Complies
Apperence	White Powder		Complies
Particle Size	100% pass 80 mesh		Complies
Oder	Characteristic		Complies
Taste	Characteristic		Complies
Loss on Drying	≤5.0%		2.20%
Residue on Ignition	≤0.1%		0.05%
Residual	≤0.1%		Complies
Residual Ethanol	≤0.5%		Complies
Heave Mentals	≤10ppm		Complies
Na	≤0.1%		<0.1%
Pb	≤3 ppm		Complies
Total Plate	<1000CFU/g		Complies
Yeast & Mold	<100 CFU /g		Complies
E. Coli	Negative		Complies
Salmonella	Negative		Complies